Sobi, a leading integrated global biopharmaceutical company dedicated to rare and difficult-to-treat diseases, announced today that Trista Morrison, an experienced corporate communications leader and former journalist, has joined the company as vice president of communications for North America.
Morrison will support Sobi’s growth in the region by building the communications function in North America and strengthening Sobi’s connection with patients, caregivers, healthcare professionals, advocacy groups and potential partners. She will also collaborate closely with the Sobi global communications team on integrated, worldwide communications initiatives.
Morrison’s more than 15 years in biopharmaceutical communications span corporate, reporter and agency roles. Most recently, Morrison served as director of corporate communications for Ironwood Pharmaceuticals, where she led internal, external and brand communications as the company transitioned from a research and development organization to a fully integrated commercial biotechnology company. Prior to her role at Ironwood, Morrison served as an editor and staff writer at BioWorld Today, covering breaking news and trends in the biopharmaceutical industry. Previously she served in various positions with biopharmaceutical-focused public relations agency Porter Novelli Life Sciences (formerly Atkins + Associates). Morrison was honored as one of PR News’ Top Women in PR in 2017, which recognizes communicators who have made bold advances in the profession.
“Sobi is a pioneer in rare and difficult-to-treat diseases, striving to create a world where patients with these conditions are diagnosed at birth and receive the care they need throughout their lives,” said Rami Levin, president of Sobi in North America. “This is an ambitious goal that requires communication and partnership between multiple stakeholders, and we look forward to working with Trista to advance this important work in North America.”
“The Sobi team is incredibly passionate about the work we do and dedicated to the patients and communities we serve. I am proud to be a part of this team and look forward to increasing our communication with key stakeholders as our business continues to grow,” said Morrison.
Source: Sobi™
The U.S. Patent and Trademark Office issued a patent to MedTrace for their method of diagnosing the human heart via 15O-water PET. The patented method is the foundation of the company’s software aQuant, currently under development. Hendrik “Hans” Harms, PhD and Senior Scientist at MedTrace, and Jens Soerensen, Professor and Clinical Advisor to MedTrace, are the originators of the method.
Teresa Graham, currently head of global product strategy for Roche pharma, will become the division’s new CEO next month, Roche said Thursday. Simultaneously, Roche is elevating Levi Garraway, chief medical officer, to the executive committee.
Fierce Pharma has obtained internal documents and video of a town hall meeting conducted this week describing what J&J called a “comprehensive review” of its portfolio. Moving forward, J&J plans to operate its vaccines and infectious diseases outfits as one group, the executives explained.
